By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

ReViral 

Stevenage Bioscience Catalyst
Gunnels Wood Road
Stevenage  Hertfordshire  SG1 2FX  United Kingdom
Phone: n/a Fax: n/a


SEARCH JOBS

ReViral is an emerging UK-based biotechnology company aiming to help patients and to enlarge the antiviral market by developing novel first-in-class compounds.

The first target is Respiratory Syncytial Virus (RSV) treatment which represents a major unmet medical need in children, the elderly and the immune-compromised. The very large number of patients provide a significant commercial opportunity. As its first program, ReViral is developing a novel, highly potent, small molecule inhibitor of RSV fusion which will enter clinical trials in H2/2016.

YEAR FOUNDED:

2011

LEADERSHIP:

Founder and CSO: Stuart Cockerill

COO: Rachel Harland

CFO: Max Herrmann

CLINICAL TRIAL:

Please click here for clinical trial information.


Key Statistics


Email: info@reviral.co.uk
Ownership: Private

Web Site: ReViral
Employees:
Symbol: 
 



Industry
Pharmaceutical






Company News
//-->